Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Shapiro

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 15, 2015
Response to Gringeri et al.: 'Recombinant full-length factor VIII (FVIII) and extended half-life FVIII products in prophylaxis--new insight provided by pharmacokinetic modelling'A D Shapiro, S Li
Journal (Indiana Dental Association)|January 1, 1991
Oral management of patients with bleeding disorders. Part 1: Medical considerationsA D Shapiro, C G McKown
The Journal of Biological Chemistry|May 12, 1995
Quantitative analysis of the interactions between prenyl Rab9, GDP dissociation inhibitor-alpha, and guanine nucleotidesA D Shapiro, S R Pfeffer
Journal (Indiana Dental Association)|March 1, 1991
Oral management of patients with bleeding disorders. 2. Dental considerationsC G McKown, A D Shapiro
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 25, 2006
An overview of the history, clinical practice concerns, comparative studies and strategies to optimize therapy of bypassing agentsR Mehta, R Parameswaran, A D Shapiro
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 23, 2013
The obstetric, gynaecological and fertility implications of homozygous PAI-1 deficiency: single-centre experienceM Heiman, S Gupta, A D Shapiro
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 22, 2001
Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxisS Björkman, A D Shapiro, E Berntorp
Methods in Enzymology|January 1, 1995
Reconstitution of Rab9 endosomal targeting and nucleotide exchange using purified Rab9-GDP dissociation inhibitor complexes and endosome-enriched membranesT Soldati, A D Shapiro, S R Pfeffer
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 27, 2014
Long-term outcomes from orthopaedic surgery in haemophilia: are we measuring success and documenting and assessing complications?A D Shapiro, S Akins, D L Cooper
Journal of Thrombosis and Haemostasis : JTH|September 29, 2018
The future of bypassing agents for hemophilia with inhibitors in the era of novel agentsA D Shapiro, I S Mitchell, S Nasr
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 15, 2015
Response to Gringeri et al.: 'Recombinant full-length factor VIII (FVIII) and extended half-life FVIII products in prophylaxis--new insight provided by pharmacokinetic modelling'A D Shapiro, S Li
Journal (Indiana Dental Association)|January 1, 1991
Oral management of patients with bleeding disorders. Part 1: Medical considerationsA D Shapiro, C G McKown
The Journal of Biological Chemistry|May 12, 1995
Quantitative analysis of the interactions between prenyl Rab9, GDP dissociation inhibitor-alpha, and guanine nucleotidesA D Shapiro, S R Pfeffer
Journal (Indiana Dental Association)|March 1, 1991
Oral management of patients with bleeding disorders. 2. Dental considerationsC G McKown, A D Shapiro
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 25, 2006
An overview of the history, clinical practice concerns, comparative studies and strategies to optimize therapy of bypassing agentsR Mehta, R Parameswaran, A D Shapiro
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 23, 2013
The obstetric, gynaecological and fertility implications of homozygous PAI-1 deficiency: single-centre experienceM Heiman, S Gupta, A D Shapiro
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 22, 2001
Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxisS Björkman, A D Shapiro, E Berntorp
Methods in Enzymology|January 1, 1995
Reconstitution of Rab9 endosomal targeting and nucleotide exchange using purified Rab9-GDP dissociation inhibitor complexes and endosome-enriched membranesT Soldati, A D Shapiro, S R Pfeffer
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 27, 2014
Long-term outcomes from orthopaedic surgery in haemophilia: are we measuring success and documenting and assessing complications?A D Shapiro, S Akins, D L Cooper
Journal of Thrombosis and Haemostasis : JTH|September 29, 2018
The future of bypassing agents for hemophilia with inhibitors in the era of novel agentsA D Shapiro, I S Mitchell, S Nasr
Pageof 8